We employed two operant assays—drinking aversion and CPA—to confirm capsaicin sensitivity in oral cancer models; we used the former assay to confirm that PAR2 mediates oral cancer-induced capsaicin sensitivity. The gene discussed is F2RL1; the disease is lip and oral cavity carcinoma.